IBEX Technologies Arthritis Biomarker 510(k) Submission Planned For 2003
This article was originally published in The Gray Sheet
Executive Summary
IBEX Technologies will seek a pharmaceutical marketing partner to launch its osteoarthritis biomarker products once they are approved as an aid in patient monitoring